PDK1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.584600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.555200E-01
Normal-vs-Stage2
4.966200E-01
Normal-vs-Stage3
8.312200E-01
Normal-vs-Stage4
7.795800E-01
Stage1-vs-Stage2
7.412600E-01
Stage1-vs-Stage3
4.731000E-01
Stage1-vs-Stage4
8.169200E-01
Stage2-vs-Stage3
3.219200E-01
Stage2-vs-Stage4
6.145800E-01
Stage3-vs-Stage4
5.794800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.559600E-01
Normal-vs-AfricanAmerican
8.065200E-01
Normal-vs-Asian
6.479200E-01
Caucasian-vs-AfricanAmerican
5.795400E-01
Caucasian-vs-Asian
7.554000E-01
AfricanAmerican-vs-Asian
7.392000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.516200E-01
Normal-vs-Female
4.658400E-01
Male-vs-Female
6.044000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.781200E-01
Normal-vs-Age(41-60Yrs)
4.440800E-01
Normal-vs-Age(61-80Yrs)
6.012200E-01
Normal-vs-Age(81-100Yrs)
6.898800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.967800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.046200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.349800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.687000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.424000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.716600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.199000E-01
Normal-vs-Daily Drinker
6.487600E-01
Normal-vs-Weekly Drinker
6.323000E-01
Normal-vs-Occasional Drinker
3.698800E-01
Normal-vs-Social Drinker
3.548000E-01
Non Drinker-vs-Daily Drinker
8.094800E-01
Non Drinker-vs-Weekly Drinker
6.766400E-01
Non Drinker-vs-Occasional Drinker
3.029200E-01
Non Drinker-vs-Social Drinker
8.565200E-01
Daily Drinker-vs-Weekly Drinker
5.742400E-01
Daily Drinker-vs-Occasional Drinker
1.667250E-01
Daily Drinker-vs-Social Drinker
5.895600E-01
Weekly Drinker-vs-Occasional Drinker
6.827800E-01
Weekly Drinker-vs-Social Drinker
7.567400E-01
Occasional Drinker-vs-Social Drinker
2.860600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.933400E-01
Normal-vs-Grade 2
2.562600E-01
Normal-vs-Grade 3
3.740200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.683290E-03
Grade 1-vs-Grade 3
3.402200E-02
Grade 1-vs-Grade 4
5.933400E-01
Grade 2-vs-Grade 3
6.365400E-01
Grade 2-vs-Grade 4
2.562600E-01
Grade 3-vs-Grade 4
3.740200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.307400E-01
Normal-vs-NonDiabetic
5.752600E-01
Diabetic-vs-NonDiabetic
4.484200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.811600E-01
Normal-vs-NoPancreatitis
6.168000E-01
Pancreatitis-vs-NoPancreatitis
8.855600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.352600E-01
Normal-vs-N1
5.176600E-01
N0-vs-N1
2.068000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.801600E-01
Normal-vs-TP53-NonMutant
9.419000E-01
TP53-Mutant-vs-TP53-NonMutant
1.523830E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
